34,884 results found

In our latest podcast, Mike Tomasulo, Danielle Williams, and DaWanna McCray discuss their key takeaways from the VLSI Technologies v. Intel jury trial and what it means for the future of patent litigation in Waco.

Inter partes reviews ("IPR") were instituted against two Pride Mobility Products Corp. patents directed to wheelchairs designed to travel over obstacles.

In Amgen Inc. v. Coherus Biosciences Inc., No. 2018-1993 (Fed. Cir. July 29, 2019), the Federal Circuit affirmed the district court's dismissal of Amgen's infringement

The option to swear behind a reference is not available in Post Grant Review (PGR) proceedings, as these proceedings only involve patents examined under the first inventor to file provisions of the AIA).

Litigation partner Michael S. Oberman's article "Sabotage of Arbitration Results in Dismissal of Lawsuit," appeared in the July 14, 2016, issue of Practice Points, published by the American Bar Association.

This morning, the United States Supreme Court granted certiorari to hear the trademark dispute involving the rock band, The Slants.

SCOTUS will not hear the Washington Redskins' trademark dispute, despite the announcement last week that it will hear the related trademark dispute involving the rock band, The Slants.

Google moved for judgment as a matter of law, which was denied. Following this denial and the ensuing $85 million damages award, Google appealed to the Federal Circuit.

Defending against complex patent cases involving multiple asserted patents and accused products can be unpredictable, expensive and difficult to control.

In PGR2015-00018, Petitioner Telebrands Corp. filed a petition for post-grant review of claims 1-14 of U.S. Patent No. 9,051,066 (filed September 2014, issued June 2015).

On Tuesday, June 20, 2016 the Supreme Court released the long awaited opinion on the standard for claim interpretation for inter partes review (IPR) and ability to appeal decisions to institute an IPR.

This Client Alert, written by Troy Smith, addresses the Supreme Court's opinion in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc.

In this article, Finnegan attorneys Margaret Esquenet and Jonathan Uffelman discuss the case.

The Supreme Court granted certiorari to review the Federal Circuit's decision in SAS Institute Inc. v. Lee, 825 F.3d 1341 (Fed. Cir. 2016).

Petitioners now have one year to file IPR petitions even if the underlying district court action is eventually voluntarily dismissed without prejudice.

The Federal Circuit just announced in MCM Portfolio LLC v. Hewlett Packard, No. 2015-1091, that the IPR process is not unconstitutional.

As we start a new decade and reflect on the changes in IP law, we've highlighted some of the top IP moments and decisions from the past 10 years.